Literature DB >> 14644453

Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.

Jeong-Ho Oak1, Kiyotaka Nakagawa, Shinichi Oikawa, Teruo Miyazawa.   

Abstract

Glycation has been implicated in the endothelial dysfunction that contributes to both diabetes- and aging-associated vascular complications. The aim of the present study was to determine whether Amadori-glycated phosphatidylethanolamine (Amadori-PE), a lipid-linked glycation compound that is formed at an increased rate in hyperglycemic states, affected proliferation, migration and tube formation of cultured human umbilical vein endothelial cells (HUVEC). Amadori-PE at a low concentration of less than 5 microM significantly enhanced these three factors involved in angiogenesis. Furthermore, stimulation of HUVEC with Amadori-PE resulted in secretion of matrix metalloproteinase 2 (MMP-2), a pivotal enzyme in the initial step of angiogenesis. Our results demonstrated for the first time that Amadori-PE may be an important compound that promotes vascular disease as a result of its angiogenic activity on endothelial cells. We also demonstrated that MMP-2 is a primary mediator of Amadori-PE-driven angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644453     DOI: 10.1016/s0014-5793(03)01237-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines.

Authors:  Lilu Guo; Venkataraman Amarnath; Sean S Davies
Journal:  Anal Biochem       Date:  2010-06-19       Impact factor: 3.365

2.  LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.

Authors:  Naoki Shoji; Kiyotaka Nakagawa; Akira Asai; Ikuko Fujita; Aya Hashiura; Yasushi Nakajima; Shinichi Oikawa; Teruo Miyazawa
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

3.  Analysis of Retina and Erythrocyte Glycerophospholipid Alterations in a Rat Model of Type 1 Diabetes.

Authors:  Todd A Lydic; Rebecca Renis; Julia V Busik; Gavin E Reid
Journal:  JALA Charlottesv Va       Date:  2009-12-01

4.  Examining the role of lipid mediators in diabetic retinopathy.

Authors:  Julia V Busik; Walter J Esselman; Gavin E Reid
Journal:  Clin Lipidol       Date:  2012-12-01

Review 5.  Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

Authors:  Sean S Davies; Lilu Guo
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

6.  Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs).

Authors:  Hua Wang; Junhong Guo; Xiaoxia Z West; Hemant K Bid; Liang Lu; Li Hong; Geeng-Fu Jang; Lei Zhang; John W Crabb; Mikhail Linetsky; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2014-11-19       Impact factor: 3.739

7.  10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Masamitsu Shimazawa; Satoshi Mishima; Hideaki Hara
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-22       Impact factor: 2.629

8.  Structural, biological and biophysical properties of glycated and glycoxidized phosphatidylethanolamines.

Authors:  Andrea Annibal; Thomas Riemer; Olga Jovanovic; Dennis Westphal; Eva Griesser; Elena E Pohl; Jürgen Schiller; Ralf Hoffmann; Maria Fedorova
Journal:  Free Radic Biol Med       Date:  2016-03-22       Impact factor: 7.376

9.  A UPLC-MRM-MS method for comprehensive profiling of Amadori compound-modified phosphatidylethanolamines in human plasma.

Authors:  Xiaobo He; Zhucui Li; Qibin Zhang
Journal:  Anal Bioanal Chem       Date:  2020-10-27       Impact factor: 4.142

10.  Non-enzymatic modification of aminophospholipids by carbonyl-amine reactions.

Authors:  Alba Naudí; Mariona Jové; Victòria Ayala; Rosanna Cabré; Manuel Portero-Otín; Reinald Pamplona
Journal:  Int J Mol Sci       Date:  2013-02-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.